Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

IBD is rising worldwide and is now a global disease. With the expanding armamentarium of medical therapies, including biologics and small molecules, there is a decline in hospitalisation rates and IBD ...

A recent randomised controlled trial showed that proton pump inhibitors (PPIs), compared with histamine-2 receptor antagonists (H2RAs), induce greater gut microbiome alterations and oral-to-gut ...

Introduction Colonic diverticulosis is the most common structural abnormality of the colon in developed countries, with an increasing global prevalence. Approximately 20–25% of affected individuals ...

3 Department of Gastroenterology, Internal Medicine, Zhongnan Hospital, Wuhan University, China Correspondence to Yi Li, Department of Gastroenterology and Hepatology, Erasmus MC, 's Gravendijkwal 230 ...

1 Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA 2 Division of Gastroenterology and Nutrition, Children's Hospital Boston and ...

a Inflammatory Bowel Disease Study Group, Royal Free Hospital School of Medicine, London, UK, b Gastroenterology Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK Dr R N Allan, Queen Elizabeth ...

1 Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands 2 Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands ...

Mayo Clinic College of Medicine, Department of Internal Medicine, Jacksonville, Florida, USA Background: Functional dyspepsia (FD) is a common disorder but there is currently little efficacious drug ...